Syndrome News and Research

RSS

Researchers examine link between gender and genetic disorder

A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).

9 Feb 2014

Talking therapy may provide effective alternative to medication for people with schizophrenia

Cognitive therapy may provide an effective alternative to antipsychotic medication for patients with schizophrenia, report researchers.

6 Feb 2014

Cognitive therapy promising for patients who shun antipsychotics

Cognitive behavioural therapy is a promising option for patients with schizophrenia who refuse to take antipsychotics, show the findings of a pilot randomised trial.

6 Feb 2014

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

A new international multi-center study led by researchers from UCSF Benioff Children's Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy that do not respond to standard antiepileptic drugs.

5 Feb 2014

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain.

4 Feb 2014

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

Edison Pharmaceuticals today announced that the US Food and Drug Administration has granted Orphan Status to vatiquinone for the treatment of Friedreich's ataxia.

4 Feb 2014

Blood pressure lowering linked with reduced risk for cognitive decline in patients with T2DM

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues.

4 Feb 2014

Study: Noninvasive prenatal testing detects 83.2% of chromosomal abnormalities

In a study to be presented on Feb. 6 at 9 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal abnormalities normally picked up by invasive diagnostic testing strategies, such as chorionic villus sampling (CVS) or amniocentesis.

4 Feb 2014

Findings recommend expectant monitoring for women with gestational hypertension

In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.

4 Feb 2014

Women ages 35+ are at decreased risk of having child with congenital malformation

In a study to be presented on Feb. 6 at 3 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that women ages 35 and older are at a decreased risk of having a child with a major congenital malformation, after excluding chromosomal abnormalities.

4 Feb 2014

Viewpoints: Obama drops 'grand bargain' talk; Mitch Mcconnell in tough spot on health law

What didn't make the cut? ... A "grand bargain": For three years, Obama pursued a big fiscal deal that would have traded higher taxes (a Democratic goal) for cuts in long-term spending on Medicare, Medicaid and Social Security (a Republican goal).

31 Jan 2014

Bubble CPAP device increases survival rate of newborns with severe respiratory illness

The first clinical study of a low-cost neonatal breathing system created by Rice University bioengineering students demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent.

31 Jan 2014

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has validated and launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer. Each of these tests is designed to investigate the most common and actionable genomic abnormalities reported for that particular tumor.

30 Jan 2014

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2013. For the three months ended December 31, 2013, Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") reported net product sales of Soliris® (eculizumab) of $441.9 million, compared to $320.5 million for the same period in 2012.

30 Jan 2014

Geranium plant extracts prevent HIV-1 from invading human cells

Extracts of the geranium plant Pelargonium sidoides inactivate human immunodeficiency virus type 1 (HIV-1) and prevent the virus from invading human cells. In the current issue of "PLOS ONE", scientists from the Helmholtz Zentrum München report that these extracts represent a potential new class of anti-HIV-1 agents for the treatment of AIDS.

30 Jan 2014

CTI announces initiation of pacritinib Phase 2 trial in AML patients with FLT3 mutations

Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.

30 Jan 2014

Obama urges Americans to sign up for coverage in State of the Union

The president extolled the health law during his State of the Union address, describing those who are benefiting and challenging Republicans for their ideas. Utah Sen. Mike Lee hit back, calling the law "an inequality Godzilla that has robbed working families of their insurance, their doctors, their wages and their jobs," while Washington Rep. Cathy McMorris Rodgers cited its troubled rollout.

29 Jan 2014

First Edition: January 29, 2014

Today's headlines include reports about how the health law played in last night's State-of-the-Union address by President Barack Obama.

29 Jan 2014

Adolescents who eat poor breakfasts display higher incidence of metabolic syndrome 27 years later

It is often said that breakfast is important for our health and a study conducted by Umeå University in Sweden, published in Public Health Nutrition supports this claim.

29 Jan 2014

Johns Hopkins researchers reveal how non-CpG methylation may contribute to Rett Syndrome

In normal development, all cells turn off genes they don’t need, often by attaching a chemical methyl group to the DNA, a process called methylation. Historically, scientists believed methyl groups could only stick to a particular DNA sequence: a cytosine followed by a guanine, called CpG. But in recent years, they have been found on other sequences, and so-called non-CpG methylation has been found in stem cells, and in neurons in the brain.

28 Jan 2014

Syndrome News and Research

Researchers examine link between gender and genetic disorder

Talking therapy may provide effective alternative to medication for people with schizophrenia

Cognitive therapy promising for patients who shun antipsychotics

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

Blood pressure lowering linked with reduced risk for cognitive decline in patients with T2DM

Study: Noninvasive prenatal testing detects 83.2% of chromosomal abnormalities

Findings recommend expectant monitoring for women with gestational hypertension

Women ages 35+ are at decreased risk of having child with congenital malformation

Viewpoints: Obama drops 'grand bargain' talk; Mitch Mcconnell in tough spot on health law

Bubble CPAP device increases survival rate of newborns with severe respiratory illness

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Geranium plant extracts prevent HIV-1 from invading human cells

CTI announces initiation of pacritinib Phase 2 trial in AML patients with FLT3 mutations

Obama urges Americans to sign up for coverage in State of the Union

First Edition: January 29, 2014

Adolescents who eat poor breakfasts display higher incidence of metabolic syndrome 27 years later

Johns Hopkins researchers reveal how non-CpG methylation may contribute to Rett Syndrome

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News